{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:23:13Z","timestamp":1788276193858,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.eprac.2022.11.008","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T01:31:51Z","timestamp":1669080711000},"page":"119-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of Lipohypertrophy in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injections or Continuous Subcutaneous Insulin Infusion"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0042-6928","authenticated-orcid":false,"given":"Tugba","family":"Barlas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Muhittin","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meric","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alev Eroglu","family":"Altinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusun Balos","family":"Toruner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ayhan","family":"Karakoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"Yetkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujde","family":"Akturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.eprac.2022.11.008_bib1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00128071-200304100-00001","article-title":"Skin-related complications of insulin therapy: epidemiology and emerging management strategies","volume":"4","author":"Richardson","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.eprac.2022.11.008_bib2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.diabres.2017.01.020","article-title":"UK lipohypertrophy interventional study","volume":"126","author":"Smith","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.eprac.2022.11.008_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ecl.2012.04.017","article-title":"Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes","volume":"41","author":"Clemmons","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.eprac.2022.11.008_bib4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3389\/fendo.2018.00638","article-title":"Insulin-related lipohypertrophy: lipogenic action or tissue trauma?","volume":"9","author":"Barola","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.eprac.2022.11.008_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.therap.2021.04.002","article-title":"A\u00a0meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy","volume":"76","author":"Wang","year":"2021","journal-title":"Therapie"},{"key":"10.1016\/j.eprac.2022.11.008_bib6","doi-asserted-by":"crossref","first-page":"9169296","DOI":"10.1155\/2022\/9169296","article-title":"Insulin-induced lipohypertrophy in patients with type 1 diabetes mellitus treated with an insulin pump","volume":"2022","author":"Ucieklak","year":"2022","journal-title":"Int J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2022.11.008_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.25179\/tjem.2020-74469","article-title":"Effect of vitamin D deficiency on the frequency of lipohypertrophy occurrence in patients with type 2 diabetes mellitus under injectable treatment","volume":"24","author":"Kira\u00e7","year":"2020","journal-title":"Turkish J Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2022.11.008_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13300-016-0161-3","article-title":"Frequency of lipohypertrophy and associated risk factors in young patients with type 1 diabetes: a cross-sectional study","volume":"7","author":"Al Hayek","year":"2016","journal-title":"Diabetes Ther"},{"issue":"5","key":"10.1016\/j.eprac.2022.11.008_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.diabet.2013.05.006","article-title":"Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes","volume":"39","author":"Blanco","year":"2013","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.eprac.2022.11.008_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/dia.2016.0334","article-title":"Lipohypertrophy in China: prevalence, risk factors, insulin consumption, and clinical impact","volume":"19","author":"Ji","year":"2017","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.eprac.2022.11.008_bib11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1177\/1932296820950688","article-title":"A\u00a0new medical device for improved rotation of insulin injections in type 1 diabetes mellitus: a proof-of-concept study","volume":"15","author":"Klarskov","year":"2021","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"Suppl 2","key":"10.1016\/j.eprac.2022.11.008_bib12","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1262-3636(10)70002-1","article-title":"New injection recommendations for patients with diabetes","volume":"36","author":"Frid","year":"2010","journal-title":"Diabetes Metab"},{"issue":"10","key":"10.1016\/j.eprac.2022.11.008_bib13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/dme.13764","article-title":"Ultrasound detection of insulin-induced lipohypertrophy in type 1 and type 2 diabetes","volume":"35","author":"Kapeluto","year":"2018","journal-title":"Diabet Med"},{"issue":"10","key":"10.1016\/j.eprac.2022.11.008_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s40618-017-0675-1","article-title":"Ultrasound characterization of insulin induced lipohypertrophy in type 1 diabetes mellitus","volume":"40","author":"Bertuzzi","year":"2017","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"9911","key":"10.1016\/j.eprac.2022.11.008_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.eprac.2022.11.008_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ando.2021.03.006","article-title":"1921-2021: from insulin discovery to islet transplantation in type 1 diabetes","volume":"82","author":"Chetboun","year":"2021","journal-title":"Ann Endocrinol (Paris)"},{"issue":"5","key":"10.1016\/j.eprac.2022.11.008_bib17","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jpeds.2007.10.006","article-title":"Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents","volume":"152","author":"Conwell","year":"2008","journal-title":"J\u00a0Pediatr"},{"issue":"13","key":"10.1016\/j.eprac.2022.11.008_bib18","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.1990.03440130090031","article-title":"Rotation of the anatomic regions used for insulin injections and day-to-day variability of plasma glucose in type I diabetic subjects","volume":"263","author":"Bantle","year":"1990","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.eprac.2022.11.008_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1570161117666190405165151","article-title":"Macrovascular complications of type 2 diabetes mellitus","volume":"18","author":"Viigimaa","year":"2020","journal-title":"Curr Vasc Pharmacol"},{"issue":"2","key":"10.1016\/j.eprac.2022.11.008_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1570161117666190502103733","article-title":"Microvascular complications of type 2 diabetes mellitus","volume":"18","author":"Faselis","year":"2020","journal-title":"Curr Vasc Pharmacol"},{"issue":"1","key":"10.1016\/j.eprac.2022.11.008_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/dc16-2215","article-title":"Glucose concentrations of less than 3.0 mmol\/L (54 mg\/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2022.11.008_bib22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s40064-016-1978-y","article-title":"A\u00a0suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes","volume":"5","author":"Gentile","year":"2016","journal-title":"Springerplus"},{"issue":"9","key":"10.1016\/j.eprac.2022.11.008_bib23","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s13300-020-00876-0","article-title":"Insulin-induced skin lipohypertrophy in type 2 diabetes: a multicenter regional survey in southern Italy","volume":"11","author":"Gentile","year":"2020","journal-title":"Diabetes Ther"},{"issue":"2","key":"10.1016\/j.eprac.2022.11.008_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002553","article-title":"Characteristics and morphology of lipohypertrophic lesions in adults with type 1 diabetes with ultrasound screening: an exploratory observational study","volume":"9","author":"Hashem","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"3","key":"10.1016\/j.eprac.2022.11.008_bib25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jdi.12742","article-title":"Prevalence of lipohypertrophy in insulin-treated diabetes patients: a systematic review and meta-analysis","volume":"9","author":"Deng","year":"2017","journal-title":"J\u00a0Diabetes Investig"},{"issue":"3","key":"10.1016\/j.eprac.2022.11.008_bib26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s12020-021-02904-w","article-title":"Insulin-related lipohypertrophy: ultrasound characteristics, risk factors, and impact of glucose fluctuations","volume":"75","author":"Lin","year":"2022","journal-title":"Endocrine"},{"issue":"29","key":"10.1016\/j.eprac.2022.11.008_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026743","article-title":"Values of ultrasound for diagnosis and management of insulin-induced lipohypertrophy: a prospective cohort study in China","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.eprac.2022.11.008_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13300-020-00954-3","article-title":"Lipohypertrophy in elderly insulin-treated patients with type 2 diabetes","volume":"12","author":"Gentile","year":"2021","journal-title":"Diabetes Ther"},{"issue":"8","key":"10.1016\/j.eprac.2022.11.008_bib29","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/pedi.13130","article-title":"Pediatric diabetes and skin disease (PeDiSkin): a cross-sectional study in 369 children, adolescents and young adults with type 1 diabetes","volume":"21","author":"Burgmann","year":"2020","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"10.1016\/j.eprac.2022.11.008_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/dia.2008.0042","article-title":"Factors associated with adherence to continuous subcutaneous insulin infusion in pediatric diabetes","volume":"11","author":"Babar","year":"2009","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2022.11.008_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13300-018-0561-7","article-title":"Impact of insulin injection and infusion routines on lipohypertrophy and glycemic control in children and adults with diabetes","volume":"10","author":"Deeb","year":"2019","journal-title":"Diabetes Ther"},{"issue":"3","key":"10.1016\/j.eprac.2022.11.008_bib32","doi-asserted-by":"crossref","first-page":"107806","DOI":"10.1016\/j.jdiacomp.2020.107806","article-title":"Subclinical lipohypertrophy\u2014easily ignored complications of insulin therapy","volume":"35","author":"Luo","year":"2021","journal-title":"J\u00a0Diabetes Complications"},{"issue":"1","key":"10.1016\/j.eprac.2022.11.008_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/CM9.0000000000000970","article-title":"Lipohypertrophy: prevalence, clinical consequence, and pathogenesis","volume":"134","author":"Xu","year":"2020","journal-title":"Chin Med J (Engl)"},{"issue":"9","key":"10.1016\/j.eprac.2022.11.008_bib34","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.mayocp.2016.06.012","article-title":"Worldwide injection technique questionnaire study: injecting complications and the role of the professional","volume":"91","author":"Frid","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.eprac.2022.11.008_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1756-0500-4-290","article-title":"Lipohypertrophy in children and adolescents with type 1 diabetes and the associated factors","volume":"4","author":"Omar","year":"2011","journal-title":"BMC Res Notes"},{"issue":"2","key":"10.1016\/j.eprac.2022.11.008_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.15171\/jcs.2018.011","article-title":"Lipohypertrophy in individuals with type 2 diabetes: prevalence and risk factors","volume":"7","author":"S\u00fcr\u00fcc\u00fc","year":"2018","journal-title":"J\u00a0Caring Sci"},{"issue":"7","key":"10.1016\/j.eprac.2022.11.008_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/dia.2018.0074","article-title":"Clinical implications of lipohypertrophy among people with type 1 diabetes in india","volume":"20","author":"Gupta","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.eprac.2022.11.008_bib38","first-page":"62","article-title":"Clinical significance of lipohypertrophy without visual and palpable changes detected by ultrasonography of subcutaneous fat","volume":"91","author":"Volkova","year":"2019","journal-title":"Ter Arkh"},{"issue":"3","key":"10.1016\/j.eprac.2022.11.008_bib39","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s13300-021-01013-1","article-title":"Injection technique education in patients with diabetes injecting insulin into areas of lipohypertrophy: a randomized controlled trial","volume":"12","author":"Chen","year":"2021","journal-title":"Diabetes Ther"},{"issue":"2","key":"10.1016\/j.eprac.2022.11.008_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.diabres.2006.12.023","article-title":"Incidence of lipohypertrophy in diabetic patients and a study of influencing factors","volume":"77","author":"Vardar","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.eprac.2022.11.008_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00592-017-1066-y","article-title":"Errors in insulin treatment management and risk of lipohypertrophy","volume":"55","author":"Pozzuoli","year":"2018","journal-title":"Acta Diabetol"},{"issue":"4","key":"10.1016\/j.eprac.2022.11.008_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0145721716648017","article-title":"Improvement of insulin injection technique: examination of current issues and recommendations","volume":"42","author":"Spollett","year":"2016","journal-title":"Diabetes Educ"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22008680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22008680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T10:05:00Z","timestamp":1722074700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22008680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1530891X22008680"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.11.008","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Lipohypertrophy in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injections or Continuous Subcutaneous Insulin Infusion","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}